Published: 20:10, February 23, 2020 | Updated: 07:30, June 6, 2023
First novel coronavirus vaccines undergo animal testing
By Zhao Yimeng

Officials emphasize on respecting scientific rules and conducting careful and safe research since vaccine development takes a long cycle. (PHOTO / IC VIA CHINADAILY.COM.CN)

The first batch of vaccines against the novel coronavirus has produced antibodies and undergone animal testing, an official of Zhejiang province's Science and Technology Department in East China said on Sunday.

Westlake University and Zhejiang province’s biology laboratory successfully resolved the receptor of coronavirus by applying cryo-electron microscopy

Song Zhiheng, deputy director of the department, said at a news conference that the recombinant adenovirus vaccine has begun cultivating recombinant virus and entered animal trials recently.

Virus filtering in Zhejiang province has stepped into the fourth generation, "but we should be aware that since vaccine development takes a long cycle, we must respect scientific rules and conduct careful and safe research," Song said.

READ MORE: Vaccine for coronavirus could be ready in 18 months, says WHO 

Westlake University and the provincial biology laboratory successfully resolved the receptor of coronavirus by applying cryo-electron microscopy, a technique performed on cryogenically cooled samples and embedded in an environment of vitreous water.

The scientific breakthrough also was announced at the news conference.

ALSO READ: Li urges vaccine, medicine development against epidemic

A laboratory under Westlake University, a private university cultivating high-level talent in advanced technology, disclosed the structure of the ACE2 receptor, the channel for novel coronavirus to enter cells, under cryo-electron microscopy in a paper released on Friday.

The results play an important role in finding and optimizing the inhibitor that stops viruses from entering cells, the university said.